EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide
Completed · Phase 1
Conditions studied: Ovarian Cancer, Colorectal Cancer, Carcinoma, Non-small-cell Lung, Prostate Cancer
In brief
This study is looking at the safety and tolerability of the experimental biological drug EMD 273066 when given with low dose cyclophosphamide to patients with recurring EpCAM positive ovarian, prostate, colorectal or non-small cell lung cancers. EMD 273066 is an experimental biological drug that may increase the immune response to certain cancers. Patients will be enrolled in groups of 3, with each successive group receiving a higher dose if the prior group adequately tolerates the study medication.
Key facts
- Study ID
- NCT00132522
- Run by
- EMD Serono
- People needed
- 45
- Starts
- 2005-05-01
- Expected to finish
- 2009-04-01
- Last updated by the study team
- 2013-10-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Recurrent non-small cell lung, colorectal, ovarian or prostate cancer
- No more than two lines of prior chemotherapy
- Positive EpCAM expression
- Karnofsky Performance Status > 70%
- Adequate laboratory results
- Normal cardiac stress test
You may not qualify if…
- Evidence of brain metastases
- Pregnant or lactating females
- Significant infection
- Prior receipt of EMD 273066
- Unable to interrupt anti-hypertensive medications 2 days prior to and through each cycle of study medication administration
- Uncontrolled hypertension
- Previous diagnosis of Addison's disease
- Previous diagnosis of an autoimmune disease
- Organ transplant
- Insulin-dependent diabetes
- History of acute pancreatitis
- Congestive heart failure
Where it is running
- City of Hope — Durate, California, United States
- Dartmouth Medical School, Pharmacology & Toxicology Dept. of Medicine — Lebanon, New Hampshire, United States
- Fox Chase Cancer Oncology Department of Medical Oncology — Philadelphia, Pennsylvania, United States
- University of Wisconsin Division of Gynecologic Oncology — Madison, Wisconsin, United States
- Centre pluridisciplinaire d'Oncologie — Lausanne, Rue Du Bugnon, Switzerland
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.